Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years

Autor: Jacque L. Duncan, Peiyao Cheng, Maureen G. Maguire, Allison A. Ayala, David G. Birch, Janet K. Cheetham, Todd A. Durham, Abigail T. Fahim, Carel B. Hoyng, Hiroshi Ishikawa, Michel Michaelides, Mark E. Pennesi, José-Alain Sahel, Katarina Stingl, Christina Y. Weng

Publikováno v: American Journal of Ophthalmology, 250, pp. 103-110
American Journal of Ophthalmology, 250, 103-110

Item does not contain fulltext

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4232da9df43f391a08bdd13e5d68bf7
https://doi.org/10.1016/j.ajo.2023.02.002

Auditory and olfactory findings in patients with USH2A ‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A ‐related retinal degeneration natural history study ( RUSH2A )

Autor: Paul S. Bernstein, Wadih M. Zein, Katarina Stingl, Isabelle Audo, Alessandro Iannaccone, Richard L. Doty, Gavin M. Bidelman, Mark H. Myers, Janet K. Cheetham, Carmen C. Brewer, Todd Durham, Jacque L. Duncan, Robert B. Hufnagel, Peiyao Cheng, Allison R Ayala, Maureen G. Maguire

Publikováno v: American Journal of Medical Genetics Part A. 185:3717-3727

Sensorineural hearing loss (SNHL) is characteristic of Usher syndrome type 2 (USH2), but less is known about SNHL in nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) and olfaction in USH2A-associated retinal degeneration. The Rate of Prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f01b2c2d50695eba288d387e660cc0f
https://doi.org/10.1002/ajmg.a.62437

Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)

Autor: Alessandro, Iannaccone, Carmen C, Brewer, Peiyao, Cheng, Jacque L, Duncan, Maureen G, Maguire, Isabelle, Audo, Allison R, Ayala, Paul S, Bernstein, Gavin M, Bidelman, Janet K, Cheetham, Richard L, Doty, Todd A, Durham, Robert B, Hufnagel, Mark H, Myers, Katarina, Stingl, Wadih M, Zein

Publikováno v: Am J Med Genet A

BACKGROUND: Sensorineural hearing loss (SNHL) is characteristic of Usher syndrome type 2 (USH2), but less is known about SNHL in nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) and olfaction in USH2A-associated retinal degeneration. METH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4b6fc4c283545bb7bf37e6796d032679
https://pubmed.ncbi.nlm.nih.gov/34331386

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

Autor: Giovanni Staurenghi, Francisco J. López, Kimmie Kim, Hohman Thomas C, Derek Y Kunimoto, David Callanan, Susan Schneider, Janet K. Cheetham, Sunil S. Patel, Sebastian Wolf, Raj K Maturi

Publikováno v: Journal of Ocular Pharmacology and Therapeutics
Callanan, David; Kunimoto, Derek; Maturi, Raj K; Patel, Sunil S; Staurenghi, Giovanni; Wolf, Sebastian; Cheetham, Janet K; Hohman, Thomas C; Kim, Kimmie; López, Francisco J; Schneider, Susan (2018). Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration. Journal of ocular pharmacology and therapeutics, 34(10), pp. 700-709. Mary Ann Liebert 10.1089/jop.2018.0062

Purpose: To evaluate safety and efficacy of the vascular endothelial growth factor binding protein abicipar pegol (abicipar) versus ranibizumab for neovascular age-related macular degeneration. Methods: Phase 2, multicenter, randomized, double-masked

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316feb66c16cd86ddf896bd0bb94c63c
https://doi.org/10.1089/jop.2018.0062

Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study

Autor: Rupert W. Strauss, Janet K. Cheetham, Mohamed Ahmed, Hendrik P. N. Scholl, Artur V. Cideciyan, José-Alain Sahel, Ann M Ervin, Xiangrong Kong, Sheila K. West, Michel Michaelides, Beatriz Munoz

Publikováno v: Ophthalmology. 124:1640-1651

Purpose To estimate the yearly rate of change of best-corrected visual acuity (BCVA) and the risk of loss 1 line or more over 1 year and to identify risk factors for BCVA loss in patients with Stargardt disease (STGD1). Design Multicenter, prospectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2be419f1037d6c2e4390b6c269d25d0
https://doi.org/10.1016/j.ophtha.2017.04.026